Tumour Registry Lung Cancer (TLK)
This trial is active, not recruiting.
|Start date||January 2010|
|End date||July 2016|
|Trial size||2500 participants|
|Trial identifier||NCT01192919, IOM TLK|
Overview of actually used therapy forms in patients with bronchial carcinoma requiring treatment.
|United States||No locations recruiting|
|Other Countries||No locations recruiting|
Patients with lung cancer requiring therapy
Documentation of actually used therapy forms in bronchial carcinoma requiring treatment
time frame: 3 years per patient
Male or female participants at least 18 years old.
Inclusion Criteria: - all patients suffering from Small Cell Lung Cancer (SCLC), Non Small Lung Cancer (NSCLC) or neuroendocrine tumors receiving therapy
|Official title||Clinical Registry Describing Treatment Reality and Therapy Modalities of Patients With Lung Cancer (NSCLC, SCLC and Neuroendocrine Tumors) Requiring Therapy.|
|Principal investigator||Hans-Werner Tessen, MD|
Call for more information